Probable risk of tumour induction after retro-orbital irradiation for Graves' ophthalmopathy

article





Snijders-Keilholz, A.

Keizer, R.J.W. de

Goslings, B.M.

Dam, E.W.C.M. van

Jansen, J.Th.M.

Broerse, J.J.
Retrobulbar irradiation for Graves' ophthalmopathy is considered as a safe treatment and has recently been recommended as the initial treatment for patients with moderately severe eye problems. However, calculations using risk factors presently known reveal a theoretical risk of radiation-induced cancer of 1.2%. Therefore, the authors suggest that this treatment should be reserved for the elderly patient, for example above the age of 40-50 years.
Topics





















Graves' ophthalmopathyProbable riskRetro-orbital irradiationTumour inductionAdultCancer riskCase reportEye diseaseFemaleGraves diseaseHumanRadiation carcinogenesisAdultAge factorsMonte Carlo MethodNeoplasms, Radiation-InducedPhantoms, ImagingProbabilityRadiotherapy dosageRadiotherapy, High-EnergyRisk FactorsSafety
TNO Identifier
233168
Repository link
https://resolver.tno.nl/uuid:64f2778b-c1b1-44a4-b471-84bf4df567a3
ISSN
0167-8140
Source
Radiotherapy and Oncology, 38(1), pp. 69-71.
Pages
69-71
Files
To receive the publication files, please send an e-mail request to TNO Repository.